BMS takeover target?

which sounds better: BristolGene or CelSquibb?

 

Say that after shareholders take their vote, politicians (majority of which in the House are democrats) agree on the deal, and Washington’s antitrust authorities give the green light.

 

as a retired Celgene employee I get a nice lump sum of cash and a boat load of BMY stock! All good as far as I’m concerned !

 

How about GeneBris (je-knee-briss)

 

Might wanna quit your job and start stand-up comedy. That’s gold Jerry, gold!

.......not

 

Bristol-Myers Squilidomide

 

Amgene @ $117 sounds a whole lot better

 

I doubt BMS can afford a bidding war.
Expect the timeline to be consolidated

 

Most feared activist investor in America, Jeffrey Smith from Starboard Value has allegedly zeroed in on BMS. Is he planning to derail the $74B Celgene buyout?

 

Celgene remains in a strong position to thrive without a deal due to a strong pipeline. Celgene doesn’t need BMS. With the house currently occupied by majority of Democrats, they’re going to scrutinize if the merger would result in higher drug prices.

 

OK !

 

BMS is sinking. Glad I left a while ago. Upper management suck and so does Lenny VP of sales.

Asco-GU – Bristol’s renal cancer lead looks to be short-lived

 

If (big IF) this deal merger goes through, Celgene sold itself cheap. BMY is acquiring CELG for it’s 4 drugs, ozanimod est. $5bil/ yr, bb2121upwards of $2bil/yr, fedratinib($2bil/ year) and Liso-cel upwards of $2bil/ yr.

 

Bogus numbers.

 

Oh yea?

 

Jeff Smith got a look at the clueless BMS management and probably shit their pants regarding their investment. Hoping to sell BMS to show lil dick Giovanni and his lil dick Ass-kissing management the door.

 

There was a tweet supposedly linked to Dealreporter about Sanofi (SNY -1.6%) mulling a run at BMY, but it is not credible.

Source: Seeking Alpha.com (Feb. 21, 2019)

 

not likely unless Starboard Value lubes SNY's in. that would be something.

 

Did I call it or what. Giovanni better get his resume ready.